Request for Covid-19 Impact Assessment of this Report
The United States Endocrine System Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Endocrine System Drugs market, reaching US$ million by the year 2028. As for the Europe Endocrine System Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Endocrine System Drugs players cover Novo Nordisk, Sanofi, Merck, and Eli Lilly, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Endocrine System Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Diabetes Drug
Human Growth Hormones
Thyroid Hormone Disorder Drugs
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Medical Center
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novo Nordisk
Sanofi
Merck
Eli Lilly
AstraZeneca
AbbVie
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Endocrine System Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Endocrine System Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Endocrine System Drugs by Country/Region, 2017, 2022 & 2028
2.2 Endocrine System Drugs Segment by Type
2.2.1 Diabetes Drug
2.2.2 Human Growth Hormones
2.2.3 Thyroid Hormone Disorder Drugs
2.2.4 Others
2.3 Endocrine System Drugs Sales by Type
2.3.1 Global Endocrine System Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Endocrine System Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Endocrine System Drugs Sale Price by Type (2017-2022)
2.4 Endocrine System Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Medical Center
2.4.4 Others
2.5 Endocrine System Drugs Sales by Application
2.5.1 Global Endocrine System Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Endocrine System Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Endocrine System Drugs Sale Price by Application (2017-2022)
3 Global Endocrine System Drugs by Company
3.1 Global Endocrine System Drugs Breakdown Data by Company
3.1.1 Global Endocrine System Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Endocrine System Drugs Sales Market Share by Company (2020-2022)
3.2 Global Endocrine System Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Endocrine System Drugs Revenue by Company (2020-2022)
3.2.2 Global Endocrine System Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Endocrine System Drugs Sale Price by Company
3.4 Key Manufacturers Endocrine System Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Endocrine System Drugs Product Location Distribution
3.4.2 Players Endocrine System Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Endocrine System Drugs by Geographic Region
4.1 World Historic Endocrine System Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Endocrine System Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Endocrine System Drugs Annual Revenue by Geographic Region
4.2 World Historic Endocrine System Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Endocrine System Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Endocrine System Drugs Annual Revenue by Country/Region
4.3 Americas Endocrine System Drugs Sales Growth
4.4 APAC Endocrine System Drugs Sales Growth
4.5 Europe Endocrine System Drugs Sales Growth
4.6 Middle East & Africa Endocrine System Drugs Sales Growth
5 Americas
5.1 Americas Endocrine System Drugs Sales by Country
5.1.1 Americas Endocrine System Drugs Sales by Country (2017-2022)
5.1.2 Americas Endocrine System Drugs Revenue by Country (2017-2022)
5.2 Americas Endocrine System Drugs Sales by Type
5.3 Americas Endocrine System Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Endocrine System Drugs Sales by Region
6.1.1 APAC Endocrine System Drugs Sales by Region (2017-2022)
6.1.2 APAC Endocrine System Drugs Revenue by Region (2017-2022)
6.2 APAC Endocrine System Drugs Sales by Type
6.3 APAC Endocrine System Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Endocrine System Drugs by Country
7.1.1 Europe Endocrine System Drugs Sales by Country (2017-2022)
7.1.2 Europe Endocrine System Drugs Revenue by Country (2017-2022)
7.2 Europe Endocrine System Drugs Sales by Type
7.3 Europe Endocrine System Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Endocrine System Drugs by Country
8.1.1 Middle East & Africa Endocrine System Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Endocrine System Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Endocrine System Drugs Sales by Type
8.3 Middle East & Africa Endocrine System Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Endocrine System Drugs
10.3 Manufacturing Process Analysis of Endocrine System Drugs
10.4 Industry Chain Structure of Endocrine System Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Endocrine System Drugs Distributors
11.3 Endocrine System Drugs Customer
12 World Forecast Review for Endocrine System Drugs by Geographic Region
12.1 Global Endocrine System Drugs Market Size Forecast by Region
12.1.1 Global Endocrine System Drugs Forecast by Region (2023-2028)
12.1.2 Global Endocrine System Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Endocrine System Drugs Forecast by Type
12.7 Global Endocrine System Drugs Forecast by Application
13 Key Players Analysis
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Endocrine System Drugs Product Offered
13.1.3 Novo Nordisk Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Endocrine System Drugs Product Offered
13.2.3 Sanofi Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Endocrine System Drugs Product Offered
13.3.3 Merck Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Eli Lilly
13.4.1 Eli Lilly Company Information
13.4.2 Eli Lilly Endocrine System Drugs Product Offered
13.4.3 Eli Lilly Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Eli Lilly Main Business Overview
13.4.5 Eli Lilly Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Endocrine System Drugs Product Offered
13.5.3 AstraZeneca Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 AbbVie
13.6.1 AbbVie Company Information
13.6.2 AbbVie Endocrine System Drugs Product Offered
13.6.3 AbbVie Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 AbbVie Main Business Overview
13.6.5 AbbVie Latest Developments
14 Research Findings and Conclusion
Table 1. Endocrine System Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Endocrine System Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Diabetes Drug
Table 4. Major Players of Human Growth Hormones
Table 5. Major Players of Thyroid Hormone Disorder Drugs
Table 6. Major Players of Others
Table 7. Global Endocrine System Drugs Sales by Type (2017-2022) & (K Pcs)
Table 8. Global Endocrine System Drugs Sales Market Share by Type (2017-2022)
Table 9. Global Endocrine System Drugs Revenue by Type (2017-2022) & ($ million)
Table 10. Global Endocrine System Drugs Revenue Market Share by Type (2017-2022)
Table 11. Global Endocrine System Drugs Sale Price by Type (2017-2022) & (USD/Pcs)
Table 12. Global Endocrine System Drugs Sales by Application (2017-2022) & (K Pcs)
Table 13. Global Endocrine System Drugs Sales Market Share by Application (2017-2022)
Table 14. Global Endocrine System Drugs Revenue by Application (2017-2022)
Table 15. Global Endocrine System Drugs Revenue Market Share by Application (2017-2022)
Table 16. Global Endocrine System Drugs Sale Price by Application (2017-2022) & (USD/Pcs)
Table 17. Global Endocrine System Drugs Sales by Company (2020-2022) & (K Pcs)
Table 18. Global Endocrine System Drugs Sales Market Share by Company (2020-2022)
Table 19. Global Endocrine System Drugs Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Endocrine System Drugs Revenue Market Share by Company (2020-2022)
Table 21. Global Endocrine System Drugs Sale Price by Company (2020-2022) & (USD/Pcs)
Table 22. Key Manufacturers Endocrine System Drugs Producing Area Distribution and Sales Area
Table 23. Players Endocrine System Drugs Products Offered
Table 24. Endocrine System Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Endocrine System Drugs Sales by Geographic Region (2017-2022) & (K Pcs)
Table 28. Global Endocrine System Drugs Sales Market Share Geographic Region (2017-2022)
Table 29. Global Endocrine System Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Endocrine System Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Endocrine System Drugs Sales by Country/Region (2017-2022) & (K Pcs)
Table 32. Global Endocrine System Drugs Sales Market Share by Country/Region (2017-2022)
Table 33. Global Endocrine System Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Endocrine System Drugs Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Endocrine System Drugs Sales by Country (2017-2022) & (K Pcs)
Table 36. Americas Endocrine System Drugs Sales Market Share by Country (2017-2022)
Table 37. Americas Endocrine System Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Endocrine System Drugs Revenue Market Share by Country (2017-2022)
Table 39. Americas Endocrine System Drugs Sales by Type (2017-2022) & (K Pcs)
Table 40. Americas Endocrine System Drugs Sales Market Share by Type (2017-2022)
Table 41. Americas Endocrine System Drugs Sales by Application (2017-2022) & (K Pcs)
Table 42. Americas Endocrine System Drugs Sales Market Share by Application (2017-2022)
Table 43. APAC Endocrine System Drugs Sales by Region (2017-2022) & (K Pcs)
Table 44. APAC Endocrine System Drugs Sales Market Share by Region (2017-2022)
Table 45. APAC Endocrine System Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Endocrine System Drugs Revenue Market Share by Region (2017-2022)
Table 47. APAC Endocrine System Drugs Sales by Type (2017-2022) & (K Pcs)
Table 48. APAC Endocrine System Drugs Sales Market Share by Type (2017-2022)
Table 49. APAC Endocrine System Drugs Sales by Application (2017-2022) & (K Pcs)
Table 50. APAC Endocrine System Drugs Sales Market Share by Application (2017-2022)
Table 51. Europe Endocrine System Drugs Sales by Country (2017-2022) & (K Pcs)
Table 52. Europe Endocrine System Drugs Sales Market Share by Country (2017-2022)
Table 53. Europe Endocrine System Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Endocrine System Drugs Revenue Market Share by Country (2017-2022)
Table 55. Europe Endocrine System Drugs Sales by Type (2017-2022) & (K Pcs)
Table 56. Europe Endocrine System Drugs Sales Market Share by Type (2017-2022)
Table 57. Europe Endocrine System Drugs Sales by Application (2017-2022) & (K Pcs)
Table 58. Europe Endocrine System Drugs Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Endocrine System Drugs Sales by Country (2017-2022) & (K Pcs)
Table 60. Middle East & Africa Endocrine System Drugs Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Endocrine System Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Endocrine System Drugs Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Endocrine System Drugs Sales by Type (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Endocrine System Drugs Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Endocrine System Drugs Sales by Application (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Endocrine System Drugs Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Endocrine System Drugs
Table 68. Key Market Challenges & Risks of Endocrine System Drugs
Table 69. Key Industry Trends of Endocrine System Drugs
Table 70. Endocrine System Drugs Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Endocrine System Drugs Distributors List
Table 73. Endocrine System Drugs Customer List
Table 74. Global Endocrine System Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 75. Global Endocrine System Drugs Sales Market Forecast by Region
Table 76. Global Endocrine System Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Endocrine System Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Endocrine System Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 79. Americas Endocrine System Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Endocrine System Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 81. APAC Endocrine System Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Endocrine System Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Europe Endocrine System Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Endocrine System Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Middle East & Africa Endocrine System Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Endocrine System Drugs Sales Forecast by Type (2023-2028) & (K Pcs)
Table 87. Global Endocrine System Drugs Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Endocrine System Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Endocrine System Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Endocrine System Drugs Sales Forecast by Application (2023-2028) & (K Pcs)
Table 91. Global Endocrine System Drugs Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Endocrine System Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Endocrine System Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 94. Novo Nordisk Basic Information, Endocrine System Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Novo Nordisk Endocrine System Drugs Product Offered
Table 96. Novo Nordisk Endocrine System Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 97. Novo Nordisk Main Business
Table 98. Novo Nordisk Latest Developments
Table 99. Sanofi Basic Information, Endocrine System Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Sanofi Endocrine System Drugs Product Offered
Table 101. Sanofi Endocrine System Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 102. Sanofi Main Business
Table 103. Sanofi Latest Developments
Table 104. Merck Basic Information, Endocrine System Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Merck Endocrine System Drugs Product Offered
Table 106. Merck Endocrine System Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 107. Merck Main Business
Table 108. Merck Latest Developments
Table 109. Eli Lilly Basic Information, Endocrine System Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Eli Lilly Endocrine System Drugs Product Offered
Table 111. Eli Lilly Endocrine System Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 112. Eli Lilly Main Business
Table 113. Eli Lilly Latest Developments
Table 114. AstraZeneca Basic Information, Endocrine System Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. AstraZeneca Endocrine System Drugs Product Offered
Table 116. AstraZeneca Endocrine System Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 117. AstraZeneca Main Business
Table 118. AstraZeneca Latest Developments
Table 119. AbbVie Basic Information, Endocrine System Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. AbbVie Endocrine System Drugs Product Offered
Table 121. AbbVie Endocrine System Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 122. AbbVie Main Business
Table 123. AbbVie Latest Developments
List of Figures
Figure 1. Picture of Endocrine System Drugs
Figure 2. Endocrine System Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Endocrine System Drugs Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Endocrine System Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Endocrine System Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Diabetes Drug
Figure 10. Product Picture of Human Growth Hormones
Figure 11. Product Picture of Thyroid Hormone Disorder Drugs
Figure 12. Product Picture of Others
Figure 13. Global Endocrine System Drugs Sales Market Share by Type in 2021
Figure 14. Global Endocrine System Drugs Revenue Market Share by Type (2017-2022)
Figure 15. Endocrine System Drugs Consumed in Hospitals
Figure 16. Global Endocrine System Drugs Market: Hospitals (2017-2022) & (K Pcs)
Figure 17. Endocrine System Drugs Consumed in Clinics
Figure 18. Global Endocrine System Drugs Market: Clinics (2017-2022) & (K Pcs)
Figure 19. Endocrine System Drugs Consumed in Medical Center
Figure 20. Global Endocrine System Drugs Market: Medical Center (2017-2022) & (K Pcs)
Figure 21. Endocrine System Drugs Consumed in Others
Figure 22. Global Endocrine System Drugs Market: Others (2017-2022) & (K Pcs)
Figure 23. Global Endocrine System Drugs Sales Market Share by Application (2017-2022)
Figure 24. Global Endocrine System Drugs Revenue Market Share by Application in 2021
Figure 25. Endocrine System Drugs Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Endocrine System Drugs Revenue Market Share by Company in 2021
Figure 27. Global Endocrine System Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Endocrine System Drugs Revenue Market Share by Geographic Region in 2021
Figure 29. Global Endocrine System Drugs Sales Market Share by Region (2017-2022)
Figure 30. Global Endocrine System Drugs Revenue Market Share by Country/Region in 2021
Figure 31. Americas Endocrine System Drugs Sales 2017-2022 (K Pcs)
Figure 32. Americas Endocrine System Drugs Revenue 2017-2022 ($ Millions)
Figure 33. APAC Endocrine System Drugs Sales 2017-2022 (K Pcs)
Figure 34. APAC Endocrine System Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Europe Endocrine System Drugs Sales 2017-2022 (K Pcs)
Figure 36. Europe Endocrine System Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Endocrine System Drugs Sales 2017-2022 (K Pcs)
Figure 38. Middle East & Africa Endocrine System Drugs Revenue 2017-2022 ($ Millions)
Figure 39. Americas Endocrine System Drugs Sales Market Share by Country in 2021
Figure 40. Americas Endocrine System Drugs Revenue Market Share by Country in 2021
Figure 41. United States Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Endocrine System Drugs Sales Market Share by Region in 2021
Figure 46. APAC Endocrine System Drugs Revenue Market Share by Regions in 2021
Figure 47. China Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Endocrine System Drugs Sales Market Share by Country in 2021
Figure 54. Europe Endocrine System Drugs Revenue Market Share by Country in 2021
Figure 55. Germany Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Endocrine System Drugs Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Endocrine System Drugs Revenue Market Share by Country in 2021
Figure 62. Egypt Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Endocrine System Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Endocrine System Drugs in 2021
Figure 68. Manufacturing Process Analysis of Endocrine System Drugs
Figure 69. Industry Chain Structure of Endocrine System Drugs
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...